An amended version of L.D. 1959 sends a clear message to Maine’s power companies: Improve your performance, get fined or be replaced.
columns
Posted inOp-eds, Opinion
Commentary: Forcing companies to diversify their boards works
A California law mandating board members from underrepresented groups was a success before a judge declared it unconstitutional.
advertisement
Posted inMaine Voices, Op-eds, Opinion
Maine Voices: Lewiston’s proposed shelter moratorium is unacceptable
Lewiston’s mayor calls opposition to efforts to help unhoused people ‘a waste of time.’
Posted inOp-eds, Opinion
The Maine Millennial: Putin’s anti-gay agenda digs in close to home
Right-wing Christians are pushing the same freedom-killing laws that took root in Russia a decade ago.
Posted inOp-eds, Opinion
Maine Observer: When clotheslines in the dooryard boom’d
A house with laundry flapping in the breeze sends an important message – somebody’s home.
Posted inOp-eds, Opinion
Insight: For U.S., it’s time to stand with world war crimes court
The U.S. has had an uneasy relationship with the International Criminal Court, which would prosecute atrocities in Ukraine, but that shouldn’t stop us from supporting it now.
Posted inGreg Kesich, Op-eds, Opinion
The View From Here: Take it from me – don’t get COVID
But the Maine CDC’s Dr. Shah says that we can look forward to better days of living with a virus that has dominated our lives for two years.
Posted inElection 2022, Op-eds, Opinion
Jim Fossel: Immigrant outreach is a smart move for Maine Republicans
A new multicultural center in Portland could signal a better approach to issues relevant to newcomers to America.
Posted inMaine Voices, Op-eds, Opinion
Maine Voices: Convergence of holy days should unite us all against anti-Muslim bigotry
As Easter, Passover and Ramadan overlap, the Shoulder-to-Shoulder Campaign can inspire us to work together on behalf of our Muslim neighbors.
Posted inOp-eds, Opinion
Commentary: Medicare is cleaning up FDA’s mess on Biogen’s Alzheimer’s drug
By clarifying what evidence it needs before it will pay for medicines like Aduhelm, the agency paved the way for improved drug innovation.